{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,2]],"date-time":"2026-09-02T17:44:32Z","timestamp":1788371072971,"version":"build-2803163510"},"reference-count":166,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2013,10,1]],"date-time":"2013-10-01T00:00:00Z","timestamp":1380585600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"name":"Higher Education Commission Pakistan"},{"DOI":"10.13039\/100008697","name":"Karachi University","doi-asserted-by":"crossref","id":[{"id":"10.13039\/100008697","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Progress in Neuro-Psychopharmacology and Biological Psychiatry"],"published-print":{"date-parts":[[2013,10]]},"DOI":"10.1016\/j.pnpbp.2013.07.015","type":"journal-article","created":{"date-parts":[[2013,7,29]],"date-time":"2013-07-29T21:31:14Z","timestamp":1375133474000},"page":"170-180","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":39,"special_numbering":"C","title":["Extending therapeutic use of psychostimulants: Focus on serotonin-1A receptor"],"prefix":"10.1016","volume":"46","author":[{"given":"Darakhshan Jabeen","family":"Haleem","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.pnpbp.2013.07.015_bb0005","first-page":"761","article-title":"Increased striatal dopamine transmission in schizophrenia: confirmation in a second cohort","volume":"155","author":"Abi-Dargham","year":"1998","journal-title":"Am J Psychiatry"},{"key":"10.1016\/j.pnpbp.2013.07.015_bb0010","doi-asserted-by":"crossref","first-page":"8104","DOI":"10.1073\/pnas.97.14.8104","article-title":"Increased baseline occupancy of D2 receptors by dopamine in schizophrenia","volume":"97","author":"Abi-Dargham","year":"2000","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.pnpbp.2013.07.015_bb0015","doi-asserted-by":"crossref","first-page":"914","DOI":"10.1016\/j.neuropharm.2006.06.001","article-title":"Attenuation by the 5-HT1A receptor agonist osemozotan of the behavioral effects of single and repeated methamphetamine in mice","volume":"51","author":"Ago","year":"2006","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.pnpbp.2013.07.015_bb0025","doi-asserted-by":"crossref","first-page":"563","DOI":"10.1038\/sj.npp.1300834","article-title":"Dissociation of psychomotor sensitization from compulsive cocaine consumption","volume":"31","author":"Ahmed","year":"2006","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.pnpbp.2013.07.015_bb0020","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1016\/j.ccm.2010.02.014","article-title":"Clinical features, diagnosis and treatment of narcolepsy","volume":"31","author":"Ahmed","year":"2010","journal-title":"Clin Chest Med"},{"key":"10.1016\/j.pnpbp.2013.07.015_bb0030","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1007\/BF00165384","article-title":"The 5-HT1A receptor selective ligands, (R)-8-OH-DPAT and (S)-UH-301, differentially affect the activity of midbrain dopamine neurons","volume":"347","author":"Arborelius","year":"1993","journal-title":"Naunyn Schmiedebergs Arch Pharmacol"},{"key":"10.1016\/j.pnpbp.2013.07.015_bb0035","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1111\/j.1748-1716.1993.tb09584.x","article-title":"(R)-8-OH-DPAT preferentially increases dopamine release in rat medial prefrontal cortex","volume":"148","author":"Arborelius","year":"1993","journal-title":"Acta Physiol Scand"},{"key":"10.1016\/j.pnpbp.2013.07.015_bb0040","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1016\/0014-2999(95)00292-S","article-title":"Differential effects of classical and newer antipsychotics on the hypermotility induced by two levels of d-amphetamine","volume":"283","author":"Arnt","year":"1995","journal-title":"Eur J Pharmacol"},{"key":"10.1016\/j.pnpbp.2013.07.015_bb0045","doi-asserted-by":"crossref","first-page":"921","DOI":"10.1021\/jm00140a002","article-title":"8-Hydroxy-2-(di-n-propylamino)tetralin, a new centrally acting 5-hydroxytryptamine receptor agonist","volume":"24","author":"Arvidsson","year":"1981","journal-title":"J Med Chem"},{"key":"10.1016\/j.pnpbp.2013.07.015_bb0050","doi-asserted-by":"crossref","first-page":"2105","DOI":"10.1021\/jm00394a029","article-title":"(+)-Cis-8-Hydroxy-1-methyl-2-(di-n-propylamino)tetralin: a potent and highly stereoselective 5-hydroxytryptamine receptor agonist","volume":"30","author":"Arvidsson","year":"1987","journal-title":"J Med Chem"},{"key":"10.1016\/j.pnpbp.2013.07.015_bb0055","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1016\/0014-2999(96)00086-6","article-title":"Effects of 5-HT1A receptor antagonists on hippocampal 5-hydroxytryptamine levels: (S)-WAY100135, but not WAY100635, has partial agonist properties","volume":"304","author":"Assie","year":"1996","journal-title":"Eur J Pharmacol"},{"key":"10.1016\/j.pnpbp.2013.07.015_bb0060","doi-asserted-by":"crossref","first-page":"1348","DOI":"10.1038\/sj.bjp.0703426","article-title":"[(3)H]-8-OH-DPAT binding in the rat brain raphe area: involvement of 5-HT(1A) and non-5-HT(1A) receptors","volume":"130","author":"Assi\u00e9","year":"2000","journal-title":"Br J Pharmacol"},{"key":"10.1016\/j.pnpbp.2013.07.015_bb0065","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1124\/jpet.105.087163","article-title":"Contrasting contribution of 5-hydroxytryptamine 1A receptor activation to neurochemical profile of novel antipsychotics: frontocortical dopamine and hippocampal serotonin release in rat brain","volume":"315","author":"Assie","year":"2005","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1016\/j.pnpbp.2013.07.015_bb0070","doi-asserted-by":"crossref","first-page":"641","DOI":"10.1002\/cne.901790311","article-title":"An autoradiographic analysis of the differential ascending projections of the dorsal and median raphe nuclei in the rat","volume":"179","author":"Azmitia","year":"1978","journal-title":"J Comp Neurol"},{"key":"10.1016\/j.pnpbp.2013.07.015_bb0075","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1177\/026988110101500108","article-title":"5-HT1A receptor in schizophrenia: a promising target for novel atypical neuroleptics?","volume":"15","author":"Bantick","year":"2001","journal-title":"J Psychopharmacol"},{"key":"10.1016\/j.pnpbp.2013.07.015_bb0080","first-page":"139","article-title":"Dietary supplementations of amino acids: evidence for enhanced serotonergic functions following haloperidol withdrawal in rat medial prefrontal cortex","volume":"19","author":"Batool","year":"2009","journal-title":"J Coll Physicians Surg Pak"},{"key":"10.1016\/j.pnpbp.2013.07.015_bb0085","first-page":"BR285","article-title":"Protective effects of aqueous fruit extract from Sea Buckthorn (Hippophae rhamnoides L. Spp. Turkestanica) on haloperidol-induced orofacial dyskinesia and neuronal alterations in the striatum","volume":"16","author":"Batool","year":"2010","journal-title":"Med Sci Monit"},{"key":"10.1016\/j.pnpbp.2013.07.015_bb0090","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1080\/0964704X.2011.595649","article-title":"The early history of the neuroscience of attention-deficit\/hyperactivity disorder","volume":"21","author":"Baumeister","year":"2012","journal-title":"J Hist Neurosci"},{"key":"10.1016\/j.pnpbp.2013.07.015_bb0095","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1016\/j.coph.2008.12.014","article-title":"Dissecting components of reward: \u2018liking\u2019, \u2018wanting\u2019, and learning","volume":"9","author":"Berridge","year":"2009","journal-title":"Curr Opin Pharmacol"},{"key":"10.1016\/j.pnpbp.2013.07.015_bb0100","doi-asserted-by":"crossref","first-page":"588","DOI":"10.1007\/BF00169129","article-title":"Piperazine derivatives including the putative anxiolytic drugs, buspirone and ipsapirone, are agonists at 5-HT1A receptors negatively coupled with adenylate cyclase in hippocampal neurons","volume":"335","author":"Bockaert","year":"1987","journal-title":"Naunyn Schmiedebergs Arch Pharmacol"},{"key":"10.1016\/j.pnpbp.2013.07.015_bb0105","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1124\/jpet.302.1.240","article-title":"Reconsideration of 5-hydroxytryptamine (5-HT)(7) receptor distribution using [(3)H]5-carboxamidotryptamine and [(3)H]8-hydroxy-2-(di-n-propylamino)tetraline: analysis in brain of 5-HT(1A) knockout and 5-HT(1A\/1B) double-knockout mice","volume":"302","author":"Bonaventure","year":"2002","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1016\/j.pnpbp.2013.07.015_bb0110","doi-asserted-by":"crossref","first-page":"745","DOI":"10.1007\/s00213-007-0698-y","article-title":"In vivo actions of aripiprazole on serotonergic and dopaminergic systems in rodent brain","volume":"191","author":"Bortolozzi","year":"2007","journal-title":"Psychopharmacology"},{"key":"10.1016\/j.pnpbp.2013.07.015_bb0115","doi-asserted-by":"crossref","first-page":"1299","DOI":"10.1017\/S146114571000009X","article-title":"Dopamine release induced by atypical antipsychotics in prefrontal cortex requires 5-HT (1A) receptors but not 5-HT(2A) receptors","volume":"13","author":"Bortolozzi","year":"2010","journal-title":"Int J Neuropsychopharmacol"},{"key":"10.1016\/j.pnpbp.2013.07.015_bb0120","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1016\/j.pbb.2009.04.019","article-title":"Low dose apomorphine induces context-specific sensitization of hypolocomotion without conditioning: support for a new state dependent retrieval hypothesis of drug conditioning and sensitization","volume":"93","author":"Braga","year":"2009","journal-title":"Pharmacol Biochem Behav"},{"key":"10.1016\/j.pnpbp.2013.07.015_bb0125","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1016\/j.bbr.2009.06.001","article-title":"Behavioral sensitization to dopaminergic inhibitory and stimulatory effects induced by low vs. high dose apomorphine treatments: an unconventional dose and response reversal sensitization challenge test reveals sensitization mechanisms","volume":"204","author":"Braga","year":"2009","journal-title":"Behav Brain Res"},{"key":"10.1016\/j.pnpbp.2013.07.015_bb0130","doi-asserted-by":"crossref","first-page":"2569","DOI":"10.1073\/pnas.94.6.2569","article-title":"Schizophrenia is associated with elevated amphetamine-induced synaptic dopamine concentrations: evidence from a novel positron emission tomography method","volume":"94","author":"Breier","year":"1997","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.pnpbp.2013.07.015_bb0135","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1007\/s00213-004-1917-4","article-title":"The 5-HT1A receptor and behavioral stimulation in the rat: effects of 8-OHDPAT on spontaneous and cocaine-induced behavior","volume":"177","author":"Carey","year":"2004","journal-title":"Psychopharmacology"},{"key":"10.1016\/j.pnpbp.2013.07.015_bb0140","doi-asserted-by":"crossref","first-page":"611","DOI":"10.1002\/cne.21073","article-title":"Quantitative mapping of tryptophan hydroxylase-2, 5-HT1A, 5-HT1B, and serotonin transporter expression across the anteroposterior axis of the rat dorsal and median raphe nuclei","volume":"498","author":"Clark","year":"2006","journal-title":"J Comp Neurol"},{"key":"10.1016\/j.pnpbp.2013.07.015_bb0145","doi-asserted-by":"crossref","first-page":"214","DOI":"10.5664\/jcsm.28112","article-title":"Severe mania complicating treatment of narcolepsy with cataplexy","volume":"7","author":"Crosby","year":"2011","journal-title":"J Clin Sleep Med"},{"issue":"Suppl. 62","key":"10.1016\/j.pnpbp.2013.07.015_bb0150","first-page":"1","article-title":"Evidence for the existence of monoamine containing neurons in the central nervous system: demonstration of monoamines in the cell bodies of brainstem neurons","volume":"232","author":"Dahlstr\u00f6m","year":"1964","journal-title":"Acta Physiol Scand"},{"key":"10.1016\/j.pnpbp.2013.07.015_bb0155","first-page":"610","article-title":"The effects of the 5- hydroxytryptamine1A agonist 8-hydroxy-2-(di-n-propylamino)tetralin on spontaneous activity, cocaine-induced hyperactivity and behavioral sensitization: a microanalysis of locomotor activity","volume":"292","author":"De La Garza","year":"2000","journal-title":"JPET"},{"key":"10.1016\/j.pnpbp.2013.07.015_bb0160","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1016\/j.pbb.2010.05.025","article-title":"Apomorphine conditioning and sensitization: the paired\/unpaired treatment order as a new major determinant of drug conditioned and sensitization effects","volume":"96","author":"de Matos","year":"2010","journal-title":"Pharmacol Biochem Behav"},{"key":"10.1016\/j.pnpbp.2013.07.015_bb0165","doi-asserted-by":"crossref","first-page":"3565","DOI":"10.1046\/j.1460-9568.1998.00368.x","article-title":"Drug-induced reinstatement of heroin- and cocaine-seeking behaviour following long-term extinction is associated with expression of behavioural sensitization","volume":"10","author":"De Vries","year":"1998","journal-title":"Eur J Neurosci"},{"key":"10.1016\/j.pnpbp.2013.07.015_bb0170","doi-asserted-by":"crossref","first-page":"687","DOI":"10.2165\/00002512-200421110-00001","article-title":"Subcutaneous apomorphine: an evidence-based review of its use in Parkinson's disease","volume":"21","author":"Deleu","year":"2004","journal-title":"Drugs Aging"},{"key":"10.1016\/j.pnpbp.2013.07.015_bb0175","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1517\/14740338.2012.675326","article-title":"Anti-obesity drugs: a review about their effects and their safety","volume":"11","author":"Derosa","year":"2012","journal-title":"Expert Opin Drug Saf"},{"key":"10.1016\/j.pnpbp.2013.07.015_bb0180","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1007\/s00213-009-1768-0","article-title":"Apomorphine-induced context-specific behavioural sensitization is prevented by the D1 antagonist SCH-23390 but potentiated and uncoupled from contextual cues by the D2 antagonist sulpiride","volume":"209","author":"Dias","year":"2010","journal-title":"Psychopharmacology"},{"key":"10.1016\/j.pnpbp.2013.07.015_bb0185","doi-asserted-by":"crossref","first-page":"10831","DOI":"10.1523\/JNEUROSCI.2999-05.2005","article-title":"Involvement of 5-HT1A receptors in prefrontal cortex in the modulation of dopaminergic activity: role in atypical antipsychotic action","volume":"25","author":"Diaz-Mataix","year":"2005","journal-title":"J Neurosci"},{"key":"10.1016\/j.pnpbp.2013.07.015_bb0190","doi-asserted-by":"crossref","first-page":"390","DOI":"10.1002\/cne.1147","article-title":"Targeting of serotonin 1A receptors to dopaminergic neurons within the parabrachial subdivision of the ventral tegmental area in rat brain","volume":"433","author":"Doherty","year":"2001","journal-title":"J Comp Neurol"},{"key":"10.1016\/j.pnpbp.2013.07.015_bb0195","first-page":"199","article-title":"The effect of repeated doses of cocaine in the rat","volume":"46","author":"Downs","year":"1932","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1016\/j.pnpbp.2013.07.015_bb0200","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1016\/j.neuropharm.2006.07.035","article-title":"Effects of amphetamine isomers, methylphenidate and atomoxetine on synaptosomal and synaptic vesicle accumulation and release of dopamine and noradrenaline in vitro in the rat brain","volume":"52","author":"Easton","year":"2007","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.pnpbp.2013.07.015_bb0205","first-page":"27","article-title":"Attention deficit\/hyperactivity disorder: pharmacotherapy","volume":"2","author":"Elia","year":"2005","journal-title":"Psychiatry (Edgmont)"},{"key":"10.1016\/j.pnpbp.2013.07.015_bb0210","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1016\/S0014-2999(99)00788-8","article-title":"Agonist-stimulated GTPgamma[35S] binding to 5-HT(1A) receptors in human post-mortem brain","volume":"386","author":"Elliott","year":"1999","journal-title":"Eur J Pharmacol"},{"key":"10.1016\/j.pnpbp.2013.07.015_bb0215","doi-asserted-by":"crossref","first-page":"751","DOI":"10.1016\/j.biopsych.2005.04.046","article-title":"Neural and behavioral plasticity associated with the transition from controlled to escalated cocaine use","volume":"58","author":"Ferrario","year":"2005","journal-title":"Biol Psychiatry"},{"key":"10.1016\/j.pnpbp.2013.07.015_bb0220","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1016\/S0079-6123(08)00918-7","article-title":"Serotonin receptors as potential targets for modulation of nicotine use and dependence","volume":"172","author":"Fletcher","year":"2008","journal-title":"Prog Brain Res"},{"key":"10.1016\/j.pnpbp.2013.07.015_bb0225","first-page":"752","article-title":"WAY-100635, a potent and selective 5-hydroxytryptamine1A antagonist, increases serotonergic neuronal activity in behaving cats: comparison with (S)-WAY-100135","volume":"278","author":"Fornal","year":"1996","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1016\/j.pnpbp.2013.07.015_bb0230","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1136\/jnnp.53.2.96","article-title":"Subcutaneous apomorphine in the treatment of Parkinson's disease","volume":"53","author":"Frankel","year":"1990","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"10.1016\/j.pnpbp.2013.07.015_bb0235","doi-asserted-by":"crossref","first-page":"1115","DOI":"10.1016\/j.pnpbp.2010.06.006","article-title":"Aripiprazole attenuates established behavioral sensitization induced by methamphetamine","volume":"34","author":"Futamura","year":"2010","journal-title":"Prog Neuropsychopharmacol Biol Psychiatry"},{"key":"10.1016\/j.pnpbp.2013.07.015_bb0240","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1016\/0014-2999(83)90404-1","article-title":"Buspirone: action on serotonin receptors in calf hippocampus","volume":"88","author":"Glaser","year":"1983","journal-title":"Eur J Pharmacol"},{"key":"10.1016\/j.pnpbp.2013.07.015_bb0245","doi-asserted-by":"crossref","first-page":"995","DOI":"10.1016\/j.neuroscience.2008.08.033","article-title":"Involvement of glutamate neurotransmission and N-methyl-d-aspartate receptor in the activation of midbrain dopamine neurons by 5-HT1A receptor agonists: an electrophysiological study in the rat","volume":"156","author":"Gronier","year":"2008","journal-title":"Neuroscience"},{"key":"10.1016\/j.pnpbp.2013.07.015_bb0250","first-page":"556","article-title":"Serotonergic modulation of dopamine neurotransmission: a mechanism for enhancing therapeutics in schizophrenia","volume":"16","author":"Haleem","year":"2006","journal-title":"J Coll Physicians Surg Pak"},{"key":"10.1016\/j.pnpbp.2013.07.015_bb0255","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1016\/j.appet.2008.07.009","article-title":"Exaggerated feedback control decreases brain serotonin concentration and elicits hyperactivity in a rat model of diet-restriction-induced anorexia nervosa","volume":"52","author":"Haleem","year":"2009","journal-title":"Appetite"},{"key":"10.1016\/j.pnpbp.2013.07.015_bb0260","series-title":"Neurochemistry, neuropharmacology and behavior","author":"Haleem","year":"2010"},{"key":"10.1016\/j.pnpbp.2013.07.015_bb0280","doi-asserted-by":"crossref","first-page":"645","DOI":"10.1016\/S0278-5846(03)00074-5","article-title":"Enhancement of serotonin-1A receptor dependent responses following withdrawal of haloperidol in rats","volume":"27","author":"Haleem","year":"2003","journal-title":"Prog Neuropsychopharmacol Biol Psychiatry"},{"key":"10.1016\/j.pnpbp.2013.07.015_bb0275","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1007\/BF01251004","article-title":"Hippocampal 5-hydroxytryptamine synthesis is greater in female rats than in males and more decreased by the 5-HT1A agonist 8-OH-DPAT","volume":"79","author":"Haleem","year":"1990","journal-title":"J Neural Transm Gen Sect"},{"key":"10.1016\/j.pnpbp.2013.07.015_bb0265","first-page":"BR354","article-title":"Differences in the effects of haloperidol and clozapine on brain serotonin and dopamine metabolism and on tests related to extrapyramidal functions in rats","volume":"8","author":"Haleem","year":"2002","journal-title":"Med Sci Monit"},{"key":"10.1016\/j.pnpbp.2013.07.015_bb0285","doi-asserted-by":"crossref","first-page":"389","DOI":"10.15288\/jsa.2002.63.389","article-title":"Serotonin and serotonin 1-A receptors in the failure of ethanol-treated rats to adapt to a repeated stress schedule","volume":"63","author":"Haleem","year":"2002","journal-title":"J Stud Alcohol"},{"key":"10.1016\/j.pnpbp.2013.07.015_bb0300","doi-asserted-by":"crossref","first-page":"1323","DOI":"10.1016\/j.pnpbp.2004.08.003","article-title":"Somatodendritic and postsynaptic serotonin-1A receptors in the attenuation of haloperidol-induced catalepsy","volume":"28","author":"Haleem","year":"2004","journal-title":"Prog Neuropsychopharmacol Biol Psychiatry"},{"key":"10.1016\/j.pnpbp.2013.07.015_bb0270","first-page":"458","article-title":"Dopamine and serotonin neurotransmission in the reinforcing effects of alcohol and apomorphine","volume":"15","author":"Haleem","year":"2005","journal-title":"J Coll Physician Surg Pak"},{"key":"10.1016\/j.pnpbp.2013.07.015_bb0290","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1016\/j.pbb.2007.04.007","article-title":"Reversal of haloperidol-induced tardive vacuous chewing movements and supersensitive somatodendritic serotonergic response by buspirone in rats","volume":"87","author":"Haleem","year":"2007","journal-title":"Pharmacol Biochem Behav"},{"key":"10.1016\/j.pnpbp.2013.07.015_bb0295","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1097\/FBP.0b013e3280dec67f","article-title":"Reversal of haloperidol-induced extrapyramidal symptoms by buspirone: a time-related study","volume":"18","author":"Haleem","year":"2007","journal-title":"Behav Pharmacol"},{"key":"10.1016\/j.pnpbp.2013.07.015_bb0305","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1016\/0006-8993(91)91156-U","article-title":"Coadministration of either a selective D1 or D2 dopamine antagonist with methamphetamine prevents methamphetamine-induced behavioral sensitization and neurochemical change, studied by in vivo intracerebral dialysis","volume":"546","author":"Hamamura","year":"1991","journal-title":"Brain Res"},{"key":"10.1016\/j.pnpbp.2013.07.015_bb0310","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1016\/j.pbb.2008.03.016","article-title":"New perspectives from microdialysis studies in freely-moving, spontaneously hypertensive rats on the pharmacology of drugs for the treatment of ADHD","volume":"90","author":"Heal","year":"2008","journal-title":"Pharmacol Biochem Behav"},{"key":"10.1016\/j.pnpbp.2013.07.015_bb0315","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1007\/PL00005259","article-title":"In vivo control of 5-hydroxytryptamine release by terminal autoreceptors in rat brain areas differentially innervated by the dorsal and median raphe nuclei","volume":"358","author":"Hervas","year":"1998","journal-title":"Naunyn Schmiedebergs Arch Pharmacol"},{"key":"10.1016\/j.pnpbp.2013.07.015_bb0320","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1016\/0031-9384(90)90275-9","article-title":"Effects of local application of 5-HT and 8-OH-DPAT into the dorsal and median raphe nuclei on motor activity in the rat","volume":"48","author":"Hillegaart","year":"1990","journal-title":"Physiol Behav"},{"key":"10.1016\/j.pnpbp.2013.07.015_bb0325","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1002\/ana.22319","article-title":"Apomorphine treatment in Alzheimer mice promoting amyloid-\u03b2 degradation","volume":"69","author":"Himeno","year":"2011","journal-title":"Ann Neurol"},{"key":"10.1016\/j.pnpbp.2013.07.015_bb0330","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1007\/s00787-012-0286-5","article-title":"Amphetamine and methylphenidate medications for attention-deficit\/hyperactivity disorder: complementary treatment options","volume":"21","author":"Hodgkins","year":"2012","journal-title":"Eur Child Adolesc Psychiatry"},{"key":"10.1016\/j.pnpbp.2013.07.015_bb0335","doi-asserted-by":"crossref","first-page":"402","DOI":"10.1007\/BF02244645","article-title":"Lack of cross-sensitization between the locomotor-activating effects of bromocriptine and those of cocaine or heroin","volume":"110","author":"Hoffman","year":"1993","journal-title":"Psychopharmacology (Berl)"},{"key":"10.1016\/j.pnpbp.2013.07.015_bb0340","doi-asserted-by":"crossref","first-page":"533","DOI":"10.1016\/S0091-3057(01)00746-8","article-title":"Molecular, pharmacological and functional diversity of 5-HT receptors","volume":"71","author":"Hoyer","year":"2002","journal-title":"Pharmacol Biochem Behav"},{"key":"10.1016\/j.pnpbp.2013.07.015_bb0350","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1016\/S0006-8993(99)02346-X","article-title":"The effect of serotonin (1A) receptor agonism on antipsychotic drug-induced dopamine release in rat striatum and nucleus accumbens","volume":"858","author":"Ichikawa","year":"2000","journal-title":"Brain Res"},{"key":"10.1016\/j.pnpbp.2013.07.015_bb0345","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1016\/0014-2999(95)00624-9","article-title":"R(+)-8-OH-DPAT, a 5-HT1A receptor agonist, inhibits amphetamine-induced dopamine release in rat striatum and nucleus accumbens","volume":"287","author":"Ichikawa","year":"1995","journal-title":"Eur J Pharmacol"},{"key":"10.1016\/j.pnpbp.2013.07.015_bb0360","doi-asserted-by":"crossref","first-page":"444","DOI":"10.1016\/j.pbb.2011.04.007","article-title":"Attenuation of apomorphine-induced sensitization by buspirone","volume":"99","author":"Ikram","year":"2011","journal-title":"Pharmacol Biochem Behav"},{"key":"10.1016\/j.pnpbp.2013.07.015_bb0355","first-page":"315","article-title":"Effects of apomorphine on locomotive activity and monoamine metabolism: a dose related study","volume":"24","author":"Ikram","year":"2011","journal-title":"Pak J Pharm Sci"},{"key":"10.1016\/j.pnpbp.2013.07.015_bb0365","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1016\/0091-3057(94)90554-1","article-title":"Dopamine receptor antagonists block amphetamine and phencyclidine-induced motor stimulation in rats","volume":"41","author":"Jackson","year":"1994","journal-title":"Pharmacol Biochem Behav"},{"key":"10.1016\/j.pnpbp.2013.07.015_bb0370","doi-asserted-by":"crossref","first-page":"3495","DOI":"10.1073\/pnas.0407737102","article-title":"Amphetamine induces dopamine efflux through a dopamine transporter channel","volume":"102","author":"Kahlig","year":"2005","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.pnpbp.2013.07.015_bb0380","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1016\/0165-0173(91)90007-U","article-title":"Dopamine transmission in the initiation and expression of drug- and stress-induced sensitization of motor activity","volume":"16","author":"Kalivas","year":"1991","journal-title":"Brain Res Brain Res Rev"},{"key":"10.1016\/j.pnpbp.2013.07.015_bb0375","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1124\/mi.6.6.7","article-title":"Animal models and brain circuits in drug addiction","volume":"6","author":"Kalivas","year":"2006","journal-title":"Mol Interv"},{"key":"10.1016\/j.pnpbp.2013.07.015_bb0385","doi-asserted-by":"crossref","first-page":"658","DOI":"10.1038\/sj.npp.1301111","article-title":"Selective serotonin reuptake inhibitors, fluoxetine and paroxetine, attenuate the expression of the established behavioral sensitization induced by methamphetamine","volume":"32","author":"Kaneko","year":"2007","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.pnpbp.2013.07.015_bb0390","first-page":"803","article-title":"Serotonergic afferent regulation of the basic physiology and pharmacological responsiveness of nigrostriatal dopamine neurons","volume":"253","author":"Kelland","year":"1990","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1016\/j.pnpbp.2013.07.015_bb0395","doi-asserted-by":"crossref","first-page":"1103","DOI":"10.1124\/jpet.107.122861","article-title":"Extended access to cocaine self-administration enhances drug-primed reinstatement but not behavioral sensitization","volume":"322","author":"Knacksted","year":"2007","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1016\/j.pnpbp.2013.07.015_bb0400","doi-asserted-by":"crossref","first-page":"951","DOI":"10.1016\/0306-4522(82)90054-9","article-title":"Identification of serotonin and non-serotonin-containing neurons of the mid-brain raphe projecting to the entorhinal area and the hippocampal formation. A combined immunohistochemical and fluorescent retrograde tracing study in the rat brain","volume":"7","author":"K\u00f6hler","year":"1982","journal-title":"Neuroscience"},{"key":"10.1016\/j.pnpbp.2013.07.015_bb0405","doi-asserted-by":"crossref","first-page":"300","DOI":"10.1021\/jm960496o","article-title":"5-HT1A-versus D2-receptor selectivity of flesinoxan and analogous N4-substituted N1-arylpiperazines","volume":"40","author":"Kuipers","year":"1997","journal-title":"J Med Chem"},{"key":"10.1016\/j.pnpbp.2013.07.015_bb0410","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1016\/0091-3057(94)90428-6","article-title":"Can post treatment with the selective dopamine D2 antagonist, YM-09151-2, inhibit induction of methamphetamine sensitization? Evaluation by ambulatory activity in mice","volume":"49","author":"Kuribara","year":"1994","journal-title":"Pharmacol Biochem Behav"},{"key":"10.1016\/j.pnpbp.2013.07.015_bb0415","doi-asserted-by":"crossref","first-page":"759","DOI":"10.1016\/0091-3057(95)00173-T","article-title":"Dopamine D1 receptor antagonist SCH 23390 retards methamphetamine sensitization in both combined administration and early posttreatment schedules in mice","volume":"52","author":"Kuribara","year":"1995","journal-title":"Pharmacol Biochem Behav"},{"key":"10.1016\/j.pnpbp.2013.07.015_bb0425","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1016\/S0006-8993(96)01111-0","article-title":"R(+)-8-OH-DPAT, a 5-HT1A receptor agonist, inhibits amphetamine-induced serotonin and dopamine release in rat medial prefrontal cortex","volume":"743","author":"Kuroki","year":"1996","journal-title":"Brain Res"},{"key":"10.1016\/j.pnpbp.2013.07.015_bb0420","doi-asserted-by":"crossref","first-page":"204","DOI":"10.1016\/S0006-8993(00)02437-9","article-title":"R(+)-8-OH-DPAT, a selective 5-HT(1A) receptor agonist, attenuated amphetamine-induced dopamine synthesis in rat striatum, but not nucleus accumbens or medial prefrontal cortex","volume":"872","author":"Kuroki","year":"2000","journal-title":"Brain Res"},{"key":"10.1016\/j.pnpbp.2013.07.015_bb0430","doi-asserted-by":"crossref","first-page":"761","DOI":"10.1007\/s00228-003-0674-3","article-title":"Effect of the novel anxiolytic drug deramciclane on the pharmacokinetics and pharmacodynamics of the CYP3A4 probe drug buspirone","volume":"59","author":"Laine","year":"2003","journal-title":"Eur J Clin Pharmacol"},{"key":"10.1016\/j.pnpbp.2013.07.015_bb0435","doi-asserted-by":"crossref","first-page":"987","DOI":"10.1523\/JNEUROSCI.3315-08.2009","article-title":"Inhibition of monoamine oxidases desensitizes 5-HT1A autoreceptors and allows nicotine to induce a neurochemical and behavioral sensitization","volume":"29","author":"Lanteri","year":"2009","journal-title":"J Neurosci"},{"key":"10.1016\/j.pnpbp.2013.07.015_bb0440","first-page":"211","article-title":"Imaging dopamine transmission in schizophrenia. A review and meta-analysis","volume":"42","author":"Laruelle","year":"1998","journal-title":"Q J Nucl Med"},{"key":"10.1016\/j.pnpbp.2013.07.015_bb0445","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1016\/S0165-0173(99)00054-5","article-title":"The role of endogenous sensitization in the pathophysiology of schizophrenia: implications from recent brain imaging studies","volume":"31","author":"Laruelle","year":"2000","journal-title":"Brain Res Brain Res Rev"},{"key":"10.1016\/j.pnpbp.2013.07.015_bb0450","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1002\/(SICI)1098-2396(199810)30:2<172::AID-SYN7>3.0.CO;2-9","article-title":"Induction of burst firing in ventral tegmental area dopaminergic neurons by activation of serotonin (5-HT) 1A receptors: WAY 100,635-reversible actions of the highly selective ligands, flesinoxan and S 15535","volume":"30","author":"Lejeune","year":"1998","journal-title":"Synapse"},{"key":"10.1016\/j.pnpbp.2013.07.015_bb0455","doi-asserted-by":"crossref","first-page":"616","DOI":"10.1038\/sj.npp.1301083","article-title":"Heroin-induced reinstatement is specific to compulsive heroin use and dissociable from heroin reward and sensitization","volume":"32","author":"Lenoir","year":"2007","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.pnpbp.2013.07.015_bb0460","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1007\/s002130050265","article-title":"8-OH-DPAT, a 5-HT1A agonist and ritanserin, a 5-HT2A\/C antagonist, reverse haloperidol-induced catalepsy in rats independently of striatal dopamine release","volume":"131","author":"Lucas","year":"1997","journal-title":"Psychopharmacology (Berl)"},{"key":"10.1016\/j.pnpbp.2013.07.015_bb0465","doi-asserted-by":"crossref","first-page":"225","DOI":"10.3233\/JAD-2011-110140","article-title":"Activation of glutathione peroxidase and inhibition of p53-related apoptosis by apomorphine","volume":"27","author":"Ma","year":"2011","journal-title":"J Alzheimers Dis"},{"key":"10.1016\/j.pnpbp.2013.07.015_bb0470","first-page":"395","article-title":"Animal models of schizophrenia: a critical review","volume":"26","author":"Marcotte","year":"2001","journal-title":"J Psychiatry Neurosci"},{"key":"10.1016\/j.pnpbp.2013.07.015_bb0475","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1254\/jjp.69.357","article-title":"Novel benzodioxan derivative, 5-(3-[((2S)-1,4-benzodioxan-2- ylmethyl) amino] propoxy)-1,3-benzodioxole HCl (MKC-242), with a highly potent and selective agonist activity at rat central serotonin1A receptors","volume":"69","author":"Matsuda","year":"1995","journal-title":"Jpn J Pharmacol"},{"key":"10.1016\/j.pnpbp.2013.07.015_bb0480","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1016\/j.jad.2011.10.043","article-title":"A morphometric, immunohistochemical, and in situ hybridization study of the dorsal raphe nucleus in major depression, bipolar disorder, schizophrenia, and suicide","volume":"137","author":"Matthews","year":"2012","journal-title":"J Affect Disord"},{"key":"10.1016\/j.pnpbp.2013.07.015_bb0485","doi-asserted-by":"crossref","first-page":"1311","DOI":"10.1037\/0735-7044.103.6.1311","article-title":"Conditioning and experiential factors affecting the development of sensitization to apomorphine","volume":"103","author":"Mattingly","year":"1989","journal-title":"Behav Neurosci"},{"key":"10.1016\/j.pnpbp.2013.07.015_bb0490","doi-asserted-by":"crossref","first-page":"15","DOI":"10.2165\/11530540-000000000-00000","article-title":"Attention-deficit hyperactivity disorder: recent advances in paediatric pharmacotherapy","volume":"70","author":"May","year":"2010","journal-title":"Drugs"},{"key":"10.1016\/j.pnpbp.2013.07.015_bb0495","doi-asserted-by":"crossref","first-page":"516","DOI":"10.2174\/138161210790361470","article-title":"Antipsychotic medication: the potential role of 5-HT1A receptor agonism","volume":"16","author":"McCreary","year":"2010","journal-title":"Curr Pharm Des"},{"key":"10.1016\/j.pnpbp.2013.07.015_bb0500","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1016\/0028-3908(93)90161-U","article-title":"Cocaine-induced behaviour: dopamine D1 receptor antagonism by SCH 23390 prevents expression of conditioned sensitisation following repeated administration of cocaine","volume":"32","author":"McCreary","year":"1993","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.pnpbp.2013.07.015_bb0510","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1016\/j.bbr.2008.05.016","article-title":"Does stimulation of 5-HT1A receptors improve cognition in schizophrenia?","volume":"195","author":"Meltzer","year":"2008","journal-title":"Behav. Brain Res"},{"key":"10.1016\/j.pnpbp.2013.07.015_bb0505","doi-asserted-by":"crossref","first-page":"1159","DOI":"10.1016\/j.pnpbp.2003.09.010","article-title":"Serotonin receptors: their key role in drugs to treat schizophrenia","volume":"27","author":"Meltzer","year":"2003","journal-title":"Prog Neuropsychopharmacol Biol Psychiatry"},{"key":"10.1016\/j.pnpbp.2013.07.015_bb0515","first-page":"853","article-title":"Improving the treatment of schizophrenia: focus on serotonin (5-HT1A) receptors","volume":"295","author":"Millan","year":"2000","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1016\/j.pnpbp.2013.07.015_bb0520","doi-asserted-by":"crossref","first-page":"941","DOI":"10.1016\/j.neuroscience.2004.06.017","article-title":"Implication of protein kinase C in the nucleus accumbens in the development of sensitization to methamphetamine in rats","volume":"127","author":"Narita","year":"2004","journal-title":"Neuroscience"},{"key":"10.1016\/j.pnpbp.2013.07.015_bb0525","first-page":"207","article-title":"Serotonergic involvement in haloperidol-induced catalepsy","volume":"265","author":"Neal-Beliveau","year":"1993","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1016\/j.pnpbp.2013.07.015_bb0530","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1038\/35053570","article-title":"Molecular basis of long-term plasticity underlying addiction","volume":"2","author":"Nestler","year":"2001","journal-title":"Nat Rev Neurosci"},{"key":"10.1016\/j.pnpbp.2013.07.015_bb0535","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1017\/S1461145704005000","article-title":"Novel antipsychotics activate recombinant human and native rat serotonin 5-HT1A receptors: affinity, efficacy and potential implications for treatment of schizophrenia","volume":"8","author":"Newman-Tancredi","year":"2005","journal-title":"Int J Neuropsychopharmacol"},{"key":"10.1016\/j.pnpbp.2013.07.015_bb0540","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1016\/0014-2999(83)90006-7","article-title":"Behavioral sensitization and relative hyperresponsiveness of striatal and limbic dopaminergic neurons after repeated methamphetamine treatment","volume":"88","author":"Nishikawa","year":"1983","journal-title":"Eur J Pharmacol"},{"key":"10.1016\/j.pnpbp.2013.07.015_bb0545","doi-asserted-by":"crossref","first-page":"619","DOI":"10.1016\/j.parkreldis.2012.01.001","article-title":"Apomorphine injections: predictors of initial common adverse events and long term tolerability","volume":"18","author":"Ondo","year":"2012","journal-title":"Parkinsonism Relat Disord"},{"key":"10.1016\/j.pnpbp.2013.07.015_bb0550","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1111\/j.1749-6632.2001.tb05786.x","article-title":"Psychostimulants in the treatment of adults with psychosis and attention deficit disorder","volume":"931","author":"Opler","year":"2001","journal-title":"Ann N Y Acad Sci"},{"key":"10.1016\/j.pnpbp.2013.07.015_bb0555","doi-asserted-by":"crossref","first-page":"308","DOI":"10.1111\/j.1600-0447.2009.01434.x","article-title":"Do the old psychostimulant drugs have a role in managing treatment-resistant depression?","volume":"121","author":"Parker","year":"2010","journal-title":"Acta Psychiatr Scand"},{"key":"10.1016\/j.pnpbp.2013.07.015_bb0560","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1016\/0006-8993(91)90453-3","article-title":"Concomitant sensitization of amphetamine-induced behavioral stimulation and in vivo dopamine release from rat caudate nucleus","volume":"538","author":"Patrick","year":"1991","journal-title":"Brain Res"},{"key":"10.1016\/j.pnpbp.2013.07.015_bb0565","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1016\/0006-8993(85)90856-X","article-title":"Quantitative autoradiographic mapping of serotonin receptors in the rat brain: I. Serotonin-1 receptors","volume":"346","author":"Pazos","year":"1985","journal-title":"Brain Res"},{"key":"10.1016\/j.pnpbp.2013.07.015_bb0570","doi-asserted-by":"crossref","first-page":"603","DOI":"10.1007\/s00213-009-1514-7","article-title":"The amphetamine sensitization model of schizophrenia: relevance beyond psychotic symptoms?","volume":"206","author":"Peleg-Raibstein","year":"2009","journal-title":"Psychopharmacology (Berl)"},{"key":"10.1016\/j.pnpbp.2013.07.015_bb0575","doi-asserted-by":"crossref","first-page":"522","DOI":"10.1016\/j.ntt.2012.07.005","article-title":"Disruption of striatal glutamatergic\/GABAergic homeostasis following acute methamphetamine in mice","volume":"34","author":"Pereira","year":"2012","journal-title":"Neurotoxicol Teratol"},{"key":"10.1016\/j.pnpbp.2013.07.015_bb0580","first-page":"304","article-title":"Pharmacology of a mixed 5-hydroxytryptamine1A\/dopamine agonist","volume":"68","author":"Piercey","year":"1983","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1016\/j.pnpbp.2013.07.015_bb0585","doi-asserted-by":"crossref","first-page":"S65","DOI":"10.1212\/WNL.0b013e31819908ce","article-title":"Treatments for Parkinson disease\u2014past achievements and current clinical needs","volume":"72","author":"Poewe","year":"2009","journal-title":"Neurology"},{"key":"10.1016\/j.pnpbp.2013.07.015_bb0590","doi-asserted-by":"crossref","first-page":"789","DOI":"10.1002\/1531-8257(200009)15:5<789::AID-MDS1005>3.0.CO;2-H","article-title":"Apomorphine: an underutilized therapy for Parkinson's disease","volume":"15","author":"Poewe","year":"2000","journal-title":"Mov Disord"},{"key":"10.1016\/j.pnpbp.2013.07.015_bb0595","doi-asserted-by":"crossref","first-page":"942","DOI":"10.1176\/ajp.2007.164.6.942","article-title":"The worldwide prevalence of ADHD: a systematic review and metaregression analysis","volume":"164","author":"Polanczyk","year":"2007","journal-title":"Am J Psychiatry"},{"key":"10.1016\/j.pnpbp.2013.07.015_bb0600","doi-asserted-by":"crossref","first-page":"440","DOI":"10.1523\/JNEUROSCI.12-02-00440.1992","article-title":"Distribution and cellular localization of mRNA coding for 5-HT1A receptor in the rat brain: correlation with receptor binding","volume":"12","author":"Pompeiano","year":"1992","journal-title":"J Neurosci"},{"key":"10.1016\/j.pnpbp.2013.07.015_bb0605","doi-asserted-by":"crossref","first-page":"731","DOI":"10.1038\/260731a0","article-title":"Increasing effects of repetitive cocaine administration in the rat","volume":"260","author":"Post","year":"1976","journal-title":"Nature"},{"key":"10.1016\/j.pnpbp.2013.07.015_bb0615","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1007\/s002130050972","article-title":"Interactions between neuroleptics and 5-HT(1A) ligands in preclinical behavioral models for antipsychotic and extrapyramidal effects","volume":"144","author":"Prinssen","year":"1999","journal-title":"Psychopharmacology (Berl)"},{"key":"10.1016\/j.pnpbp.2013.07.015_bb0610","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1016\/S0014-2999(02)02430-5","article-title":"5-HT1A receptor activation and anti-cataleptic effects: high-efficacy agonists maximally inhibit haloperidol-induced catalepsy","volume":"453","author":"Prinssen","year":"2002","journal-title":"Eur J Pharmacol"},{"key":"10.1016\/j.pnpbp.2013.07.015_bb0620","doi-asserted-by":"crossref","first-page":"699","DOI":"10.1097\/00008877-199712000-00004","article-title":"Stimulation of serotonin (5-HT) 1A receptors attenuates the locomotor, but not the discriminative, effects of amphetamine and cocaine in rats","volume":"8","author":"Przegali\u00f1ski","year":"1997","journal-title":"Behav Pharmacol"},{"key":"10.1016\/j.pnpbp.2013.07.015_bb0625","doi-asserted-by":"crossref","first-page":"1011","DOI":"10.1016\/S0024-3205(99)00666-9","article-title":"Activation of serotonin (5-HT) 1A receptors inhibits amphetamine sensitization in mice","volume":"66","author":"Przegalinski","year":"2000","journal-title":"Life Sci"},{"key":"10.1016\/j.pnpbp.2013.07.015_bb0630","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1002\/(SICI)1096-9861(20000207)417:2<181::AID-CNE4>3.0.CO;2-A","article-title":"Somatodendritic localization of 5-HT1A and preterminal axonal localization of 5-HT1B serotonin receptors in adult rat brain","volume":"417","author":"Riad","year":"2000","journal-title":"J Comp Neurol"},{"key":"10.1016\/j.pnpbp.2013.07.015_bb0635","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1016\/0165-0173(86)90002-0","article-title":"Enduring changes in brain and behavior produced by chronic amphetamine administration: a review and evaluation of animal models of amphetamine psychosis","volume":"11","author":"Robinson","year":"1986","journal-title":"Brain Res Rev"},{"key":"10.1016\/j.pnpbp.2013.07.015_bb0640","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1016\/0165-0173(93)90013-P","article-title":"The neural basis of drug craving: an incentive sensitization theory of addiction","volume":"18","author":"Robinson","year":"1993","journal-title":"Brain Res Brain Res Rev"},{"key":"10.1016\/j.pnpbp.2013.07.015_bb0645","doi-asserted-by":"crossref","first-page":"S91","DOI":"10.1046\/j.1360-0443.95.8s2.19.x","article-title":"The psychology and neurobiology of addiction: an incentive-sensitization view","volume":"95","author":"Robinson","year":"2000","journal-title":"Addiction"},{"key":"10.1016\/j.pnpbp.2013.07.015_bb0650","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1046\/j.1360-0443.2001.9611038.x","article-title":"Incentive-sensitization and addiction","volume":"96","author":"Robinson","year":"2001","journal-title":"Addiction"},{"key":"10.1016\/j.pnpbp.2013.07.015_bb0655","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1146\/annurev.psych.54.101601.145237","article-title":"Addiction","volume":"54","author":"Robinson","year":"2003","journal-title":"Annu Rev Psychol"},{"key":"10.1016\/j.pnpbp.2013.07.015_bb0660","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1016\/0006-8993(88)90549-5","article-title":"Persistent sensitization of dopamine neurotransmission in ventral striatum (nucleus accumbens) produced by prior experience with (+)-amphetamine: a microdialysis study in freely moving rats","volume":"462","author":"Robinson","year":"1988","journal-title":"Brain Res"},{"key":"10.1016\/j.pnpbp.2013.07.015_bb0665","doi-asserted-by":"crossref","first-page":"R3","DOI":"10.1016\/S0014-2999(97)81951-6","article-title":"Clozapine increases dopamine release in prefrontal cortex by 5-HT1A receptor activation","volume":"338","author":"Rollema","year":"1997","journal-title":"Eur J Pharmacol"},{"key":"10.1016\/j.pnpbp.2013.07.015_bb0670","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1016\/S0006-3223(00)00850-7","article-title":"5-HT (1A) receptor activation contributes to ziprasidone-induced dopamine release in the rat prefrontal cortex","volume":"48","author":"Rollema","year":"2000","journal-title":"Biol Psychiatry"},{"key":"10.1016\/j.pnpbp.2013.07.015_bb0675","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1002\/syn.890200304","article-title":"Repeated quinpirole treatment: locomotor activity, dopamine synthesis, and effects of selective dopamine antagonists","volume":"20","author":"Rowlett","year":"1995","journal-title":"Synapse"},{"key":"10.1016\/j.pnpbp.2013.07.015_bb0680","first-page":"173","article-title":"Neurochemical and behavioral effects of 8-OH-DPAT following exposure to restraint stress in rats","volume":"59","author":"Samad","year":"2007","journal-title":"Pharmacol Rep"},{"key":"10.1016\/j.pnpbp.2013.07.015_bb0685","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1016\/j.neuroimage.2012.07.001","article-title":"Normative database of the serotonergic system in healthy subjects using multi-tracer PET","volume":"63","author":"Savli","year":"2012","journal-title":"Neuroimage"},{"key":"10.1016\/j.pnpbp.2013.07.015_bb0690","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1111\/j.1467-789X.2004.00149.x","article-title":"Psychiatric medication-induced obesity: treatment options","volume":"5","author":"Schwartz","year":"2004","journal-title":"Obes Rev"},{"key":"10.1016\/j.pnpbp.2013.07.015_bb0695","doi-asserted-by":"crossref","first-page":"989","DOI":"10.1111\/j.1476-5381.1989.tb14630.x","article-title":"Pharmacological characterization of 8-OH-DPAT-induced inhibition of rat hippocampal 5-HT release in vivo as measured by microdialysis","volume":"98","author":"Sharp","year":"1989","journal-title":"Br J Pharmacol"},{"key":"10.1016\/j.pnpbp.2013.07.015_bb0700","first-page":"753","article-title":"Motor effects of buspirone: relationship with dopamine and serotonin in the striatum","volume":"15","author":"Shireen","year":"2005","journal-title":"J Coll Physicians Surg Pak"},{"key":"10.1016\/j.pnpbp.2013.07.015_bb0705","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1111\/j.1755-5949.2010.00218.x","article-title":"Treatment of the psychostimulant-sensitized animal model of schizophrenia","volume":"17","author":"Shuto","year":"2011","journal-title":"CNS Neurosci Ther"},{"key":"10.1016\/j.pnpbp.2013.07.015_bb0710","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1007\/s00213-006-0621-y","article-title":"Interaction of the novel antipsychotic aripiprazole with 5-HT1A and 5-HT2A receptors: functional receptor-binding and in vivo electrophysiological studies","volume":"190","author":"Stark","year":"2007","journal-title":"Psychopharmacology"},{"key":"10.1016\/j.pnpbp.2013.07.015_bb0715","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/j.bbr.2011.01.026","article-title":"Serotonergic involvement in methamphetamine-induced locomotor activity: a detailed pharmacological study","volume":"220","author":"Steed","year":"2011","journal-title":"Behav Brain Res"},{"key":"10.1016\/j.pnpbp.2013.07.015_bb0720","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1016\/0006-8993(95)00938-M","article-title":"Effect of repeated methamphetamine administrations on dopamine and glutamate efflux in rat prefrontal cortex","volume":"700","author":"Stephans","year":"1995","journal-title":"Brain Res"},{"key":"10.1016\/j.pnpbp.2013.07.015_bb0725","doi-asserted-by":"crossref","first-page":"733","DOI":"10.1248\/bpb.28.733","article-title":"Inhibitory effects of the 5-HT(1A) receptor agonist buspirone on stress-induced hyperglycemia in mice: involvement of insulin and a buspirone metabolite, 1-(2-pyrimidinyl)piperazine (1-PP)","volume":"28","author":"Sugimoto","year":"2005","journal-title":"Biol Pharm Bull"},{"key":"10.1016\/j.pnpbp.2013.07.015_bb0730","doi-asserted-by":"crossref","first-page":"406","DOI":"10.1016\/j.pneurobio.2005.04.003","article-title":"Mechanisms of neurotransmitter release by amphetamines: a review","volume":"75","author":"Sulzer","year":"2005","journal-title":"Prog Neurobiol"},{"key":"10.1016\/j.pnpbp.2013.07.015_bb0735","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1016\/j.schres.2007.06.008","article-title":"Effect of buspirone, a serotonin1A partial agonist, on cognitive function in schizophrenia: a randomized, double-blind, placebo-controlled study","volume":"95","author":"Sumiyoshi","year":"2007","journal-title":"Schizophr Res"},{"key":"10.1016\/j.pnpbp.2013.07.015_bb0740","doi-asserted-by":"crossref","first-page":"607","DOI":"10.1001\/archpsyc.1994.03950080019003","article-title":"High-dose selegiline in treatment-resistant older depressive patients","volume":"51","author":"Sunderland","year":"1994","journal-title":"Arch Gen Psychiatry"},{"key":"10.1016\/j.pnpbp.2013.07.015_bb0745","doi-asserted-by":"crossref","first-page":"921","DOI":"10.1016\/0091-3057(94)90201-1","article-title":"Effects of dose and interdose interval on locomotor sensitization to the dopamine agonist quinpirole","volume":"48","author":"Szechtman","year":"1994","journal-title":"Pharmacol Biochem Behav"},{"key":"10.1016\/j.pnpbp.2013.07.015_bb0755","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1016\/j.ejphar.2005.02.051","article-title":"Aripiprazole's low intrinsic activities at human dopamine D2L and D2S receptors render it a unique antipsychotic","volume":"515","author":"Tadori","year":"2005","journal-title":"Eur J Pharmacol"},{"key":"10.1016\/j.pnpbp.2013.07.015_bb0750","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1016\/j.ejphar.2007.07.031","article-title":"Difference in agonist\/antagonist properties at human dopamine D2 receptors between aripiprazole, bifeprunox and SDZ 208-912","volume":"574","author":"Tadori","year":"2007","journal-title":"Eur J Pharmacol"},{"key":"10.1016\/j.pnpbp.2013.07.015_bb0760","doi-asserted-by":"crossref","first-page":"514","DOI":"10.1001\/archpsyc.59.6.514","article-title":"Brain serotonin 5-HT(1A) receptor binding in schizophrenia measured by positron emission tomography and [11C]WAY-100635","volume":"59","author":"Tauscher","year":"2002","journal-title":"Arch Gen Psychiatry"},{"key":"10.1016\/j.pnpbp.2013.07.015_bb0765","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1016\/S1389-9457(00)00081-2","article-title":"Current concepts in the etiology, diagnosis and treatment of narcolepsy","volume":"2","author":"Thorpy","year":"2001","journal-title":"Sleep Med"},{"key":"10.1016\/j.pnpbp.2013.07.015_bb0770","doi-asserted-by":"crossref","first-page":"673","DOI":"10.1002\/jnr.21145","article-title":"Role of m-opioid receptor in modulation of preproenkephalin mRNA expression and opioid and dopamine receptor binding in methamphetamine-sensitized mice","volume":"85","author":"Tien","year":"2007","journal-title":"J Neurosci Res"},{"key":"10.1016\/j.pnpbp.2013.07.015_bb0775","doi-asserted-by":"crossref","first-page":"375","DOI":"10.4103\/0253-7613.83104","article-title":"A brief review on recent developments in animal models of schizophrenia","volume":"43","author":"Trivedi","year":"2011","journal-title":"Indian J Pharm"},{"key":"10.1016\/j.pnpbp.2013.07.015_bb0780","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1007\/s11920-002-0024-7","article-title":"Stimulant-induced psychosis and schizophrenia: the role of sensitization","volume":"4","author":"Ujike","year":"2002","journal-title":"Curr Psychiatry Rep"},{"key":"10.1016\/j.pnpbp.2013.07.015_bb0785","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1196\/annals.1316.035","article-title":"Clinical features of sensitization to methamphetamine observed in patients with methamphetamine dependence and psychosis","volume":"1025","author":"Ujike","year":"2004","journal-title":"Ann N Y Acad Sci"},{"key":"10.1016\/j.pnpbp.2013.07.015_bb0795","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1007\/s002130000493","article-title":"Alterations in dopaminergic and glutamatergic transmission in the induction and expression of behavioral sensitization: a critical review of preclinical studies","volume":"151","author":"Vanderschuren","year":"2000","journal-title":"Psychopharmacology (Berl)"},{"key":"10.1016\/j.pnpbp.2013.07.015_bb0800","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1007\/7854_2009_21","article-title":"Sensitization processes in drug addiction","volume":"3","author":"Vanderschuren","year":"2010","journal-title":"Curr Top Behav Neurosci"},{"key":"10.1016\/j.pnpbp.2013.07.015_bb0805","doi-asserted-by":"crossref","first-page":"842","DOI":"10.1176\/appi.ps.53.7.842","article-title":"Body weight changes associated with psychopharmacology","volume":"53","author":"Vanina","year":"2002","journal-title":"Psychiatr Serv"},{"key":"10.1016\/j.pnpbp.2013.07.015_bb0810","doi-asserted-by":"crossref","first-page":"827","DOI":"10.1016\/j.neubiorev.2003.11.001","article-title":"Sensitization of midbrain dopamine neuron reactivity and the self-administration of psychomotor stimulant drugs","volume":"27","author":"Vezina","year":"2004","journal-title":"Neurosci Biobehav Rev"},{"key":"10.1016\/j.pnpbp.2013.07.015_bb0815","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1016\/0006-8993(78)90578-4","article-title":"Decreased locomotor activity and attenuation of amphetamine hyperactivity with intraventricular infusion of serotonin in the rat","volume":"143","author":"Warbritton","year":"1978","journal-title":"Brain Res"},{"key":"10.1016\/j.pnpbp.2013.07.015_bb0820","first-page":"249","article-title":"Differential development of autoreceptor subsensitivity and enhanced dopamine release during amphetamine sensitization","volume":"264","author":"Wolf","year":"1993","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1016\/j.pnpbp.2013.07.015_bb0825","doi-asserted-by":"crossref","first-page":"1558","DOI":"10.1126\/science.2878495","article-title":"Positron emission tomography reveals elevated D2 dopamine receptors in drug-naive schizophrenics","volume":"234","author":"Wong","year":"1986","journal-title":"Science"},{"key":"10.1016\/j.pnpbp.2013.07.015_bb0830","doi-asserted-by":"crossref","first-page":"274","DOI":"10.1002\/syn.20726","article-title":"GABA (A) receptors mediate the attenuating effects of a 5-HT(3) receptor antagonist on methamphetamine-induced behavioral sensitization in mice","volume":"64","author":"Yoo","year":"2010","journal-title":"Synapse"},{"key":"10.1016\/j.pnpbp.2013.07.015_bb0835","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1007\/BF00969884","article-title":"Regulation of nucleus accumbens dopamine release by the dorsal raphe nucleus in the rat","volume":"17","author":"Yoshimoto","year":"1992","journal-title":"Neurochem Res"}],"container-title":["Progress in Neuro-Psychopharmacology and Biological Psychiatry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0278584613001577?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0278584613001577?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,5,15]],"date-time":"2024-05-15T16:11:14Z","timestamp":1715789474000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0278584613001577"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,10]]},"references-count":166,"alternative-id":["S0278584613001577"],"URL":"https:\/\/doi.org\/10.1016\/j.pnpbp.2013.07.015","relation":{},"ISSN":["0278-5846"],"issn-type":[{"value":"0278-5846","type":"print"}],"subject":[],"published":{"date-parts":[[2013,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Extending therapeutic use of psychostimulants: Focus on serotonin-1A receptor","name":"articletitle","label":"Article Title"},{"value":"Progress in Neuro-Psychopharmacology and Biological Psychiatry","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.pnpbp.2013.07.015","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2013 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}